相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
Christopher Douville et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
Ji Yun Lee et al.
TRANSLATIONAL ONCOLOGY (2018)
Aging and the rise of somatic cancer-associated mutations in normal tissues
Rosa Ana Risques et al.
PLOS GENETICS (2018)
Diagnostic dilemmas in patients with upper tract urothelial carcinoma
Joyce Baard et al.
NATURE REVIEWS UROLOGY (2017)
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2017)
TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential
Liang Cheng et al.
EUROPEAN UROLOGY (2017)
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma
Tyler J. Moss et al.
EUROPEAN UROLOGY (2017)
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
Maria Del Carmen Rodriguez Pena et al.
VIRCHOWS ARCHIV (2017)
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
K. M. Patel et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Anticipatory Positive Urine Tests for Bladder Cancer
Ajay Gopalakrishna et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology
Guliz A. Barkan et al.
ADVANCES IN ANATOMIC PATHOLOGY (2016)
The cytomorphological features of low-grade urothelial neoplasms vary by specimen type
Mingjuan L. Zhang et al.
CANCER CYTOPATHOLOGY (2016)
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
Fiona S. Togneri et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder
Morgan L. Cowan et al.
HUMAN PATHOLOGY (2016)
Emerging Bladder Cancer Biomarkers and Targets of Therapy
George J. Netto et al.
UROLOGIC CLINICS OF NORTH AMERICA (2016)
High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma
Doreen Nguyen et al.
VIRCHOWS ARCHIV (2016)
The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients
Xiaotian Yuan et al.
ONCOTARGET (2016)
Diagnostic potential of tumor DNA from ovarian cyst fluid
Yuxuan Wang et al.
ELIFE (2016)
Genomic Characterization of Upper Tract Urothelial Carcinoma
John P. Sfakianos et al.
EUROPEAN UROLOGY (2015)
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2015)
Epigenetic biomarkers in the blood of patients with urological malignancies
Joerg Ellinger et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Simeon Springer et al.
GASTROENTEROLOGY (2015)
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
Josh Lewis Stern et al.
GENES & DEVELOPMENT (2015)
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
Yuxuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Yuxuan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
The role of diagnostic ureteroscopy in the era of computed tomography urography
Shay Golan et al.
BMC UROLOGY (2015)
Mutation signatures implicate aristolochic acid in bladder cancer development
Song Ling Poon et al.
GENOME MEDICINE (2015)
Low- and high-grade bladder cancer appraisal via serum-based proteomics approach
Navneeta Bansal et al.
CLINICA CHIMICA ACTA (2014)
Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies
Bernhard Ralla et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2014)
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
Yves Allory et al.
EUROPEAN UROLOGY (2014)
Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine
Carolyn D. Hurst et al.
EUROPEAN UROLOGY (2014)
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma
Glynis A. Scott et al.
MODERN PATHOLOGY (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
Kun Wang et al.
ONCOTARGET (2014)
Clinical Applications of Recent Molecular Advances in Urologic Malignancies: No Longer Chasing a Mirage?
George J. Netto
ADVANCES IN ANATOMIC PATHOLOGY (2013)
Evaluation of UroVysion and Cytology for Bladder Cancer Detection
Haythem Dimashkieh et al.
CANCER CYTOPATHOLOGY (2013)
TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
Isaac Kinde et al.
CANCER RESEARCH (2013)
Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease
Arthur P. Grollman
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2013)
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
Chung-Hsin Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
David A. Green et al.
JOURNAL OF UROLOGY (2013)
Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid
M. Hollstein et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Margaret L. Hoang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Biomonitoring of Aristolactam-DNA Adducts in Human Tissues Using Ultra-Performance Liquid Chromatography/Ion-Trap Mass Spectrometry
Byeong Hwa Yun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
Rodney Davis et al.
JOURNAL OF UROLOGY (2012)
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
Bojan Jelakovic et al.
KIDNEY INTERNATIONAL (2012)
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
George J. Netto
NATURE REVIEWS UROLOGY (2012)
FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
Isaac Kinde et al.
PLOS ONE (2012)
A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
Steve Goodison et al.
PLOS ONE (2012)
Aristolochic acid-associated urothelial cancer in Taiwan
Chung-Hsin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events
Reza R. Serizawa et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
TP53 Mutational signature for aristolochic acid: an environmental carcinogen
Masaaki Moriya et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma
Shahrokh F. Shariat et al.
WORLD JOURNAL OF UROLOGY (2011)
Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk
Ming-Nan Lai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Theranostic and prognostic biomarkers: genomic applications in urological malignancies
George J. Netto et al.
PATHOLOGY (2010)
Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine
Hui-Hui Lin et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology
Shigeto Kawauchi et al.
HUMAN PATHOLOGY (2009)
Significant Predictive Factors for Prognosis of Primary Upper Urinary Tract Cancer after Radical Nephroureterectomy in Taiwanese Patients
Ching-Chia Li et al.
EUROPEAN UROLOGY (2008)
UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing
Tine Hajdinjak
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: Prospective study with 13 years' follow-up
Said Fadel Mishriki et al.
UROLOGY (2008)
Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003
Shu-Ching Hsieh et al.
Chinese Medicine (2008)
UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer
Paula M. J. Moonen et al.
EUROPEAN UROLOGY (2007)
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis
Lan Mo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria
MF Sarosdy et al.
JOURNAL OF UROLOGY (2006)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
AS Levey et al.
KIDNEY INTERNATIONAL (2005)
Urothelial tumorigenesis: A tale of divergent pathways
XR Wu
NATURE REVIEWS CANCER (2005)
Studies on the toxicity of Aristolochia manshuriensis (Guanmuton)
SL Hu et al.
TOXICOLOGY (2004)
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
D Dressman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology
M Skacel et al.
JOURNAL OF UROLOGY (2003)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan
MH Yang et al.
UROLOGY (2002)
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice
MH Khadra et al.
JOURNAL OF UROLOGY (2000)
分享论文
